STOCK TITAN

Goodness Growth Holdings to Report Third Quarter Results on November 10, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Goodness Growth Holdings, a science-focused cannabis company, will report its third quarter financial results on November 10, 2021, before market opening. The results will cover the period ending September 30, 2021. A conference call and webcast to discuss these results will take place at 8:30 a.m. Eastern Time on the same day. Interested attendees can register here. Goodness Growth is also noted for its subsidiaries, including Vireo Health, and its operations span across eight markets in the U.S.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, Nov. 2, 2021 /PRNewswire/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP incubator, today announced that it will report financial results for its third quarter ended September 30, 2021 on Wednesday, November 10, 2021 before the market opens. 

The Company will hold a conference call and webcast to discuss its business and financial results that same day at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). Interested parties may register to attend the call via this link: http://www.directeventreg.com/registration/event/1664907.

Upon registration, each participant will be provided with call details and a registrant ID for Goodness Growth's conference ID number 1664907. A live audio webcast of the call will also be available in the Events & Presentations section of the Company's investor relations website. A webcast replay will be made available for one year on the Company's website.

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, and its science and intellectual property incubator, Resurgent Biosciences. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites, and distributes its products through its growing network of Green Goods™ and other retail locations and third-party dispensaries. Its teams of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States. For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com.

Contact Information


Investor Inquiries:

Media Inquiries:

Sam Gibbons

Albe Zakes

Vice President, Investor Relations

Vice President, Corporate Communications

samgibbons@vireohealth.com   

albezakes@vireohealth.com      

(612) 314-8995

(267) 221-4800

 


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/goodness-growth-holdings-to-report-third-quarter-results-on-november-10-2021-301413805.html

SOURCE Goodness Growth Holdings, Inc.

FAQ

What date will Goodness Growth Holdings report its Q3 results in 2021?

Goodness Growth Holdings will report its Q3 results on November 10, 2021.

What time is the conference call for Goodness Growth Holdings on November 10, 2021?

The conference call will take place at 8:30 a.m. Eastern Time on November 10, 2021.

How can I register for the Goodness Growth Holdings conference call?

You can register for the conference call by visiting this link: http://www.directeventreg.com/registration/event/1664907.

What period does the Q3 report for Goodness Growth Holdings cover?

The Q3 report covers the period ending September 30, 2021.

In how many markets does Goodness Growth Holdings operate?

Goodness Growth Holdings operates in eight markets across the United States.

GOODNESS GROWTH HLDGS INC

OTC:GDNSF

GDNSF Rankings

GDNSF Latest News

GDNSF Stock Data

61.05M
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
Vancouver